Frank Schleck's Tour B sample also positive for banned substance

Frank Schleck on stage three, Ruta del Sol 2012

A second sample of Frank Schleck's urine taken on Saturday July 14 during the 2012 Tour de France has also tested positive for a banned substance, both the Luxembourg rider  and UCI confirmed on Friday.

The Union Cycliste Internationale (UCI) announced on Tuesday that the World Anti-Doping Agency accredited Châtenay-Malabry laboratory had detected banned diruetic xipamide in Schleck's A sample. Schleck then took up his right to have the B sample tested, and this has also returned a positive for xipamide, according to the UCI.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Nigel Wynn
Former Associate Editor

Nigel Wynn worked as associate editor on CyclingWeekly.com, he worked almost single-handedly on the Cycling Weekly website in its early days. His passion for cycling, his writing and his creativity, as well as his hard work and dedication, were the original driving force behind the website’s success. Without him, CyclingWeekly.com would certainly not exist on the size and scale that it enjoys today. Nigel sadly passed away, following a brave battle with a cancer-related illness, in 2018. He was a highly valued colleague, and more importantly, an exceptional person to work with - his presence is sorely missed.